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Case Report
Pulmonary Manifestations and Management of
Proteus Syndrome
Chia-Ying Li,1 Yih-Leong Chang,2 Wei-Chou Chen,1 Yung-Chie Lee1*
Proteus syndrome is a very rare, sporadic and congenital condition that is characterized by postnatal 
mosaic overgrowth. This disorder is thought to be caused by a somatic gene mutation, but the exact etiol-
ogy is unknown. Commonly involved tissues include connective tissue, bone, skin and the central nervous
system. Another less common symptom involves pulmonary emphysematous changes. This report docu-
ments a 25-year-old man with Proteus syndrome who presented with progressive exertional dyspnea and
asymmetric overgrowth of his extremities. He underwent left pneumonectomy and his postoperative
course was uneventful. Lung tissue showed emphysematous changes with multiple bulla formation and
scattered calcification. We also review recent literature related to pulmonary manifestations and manage-
ment of Proteus syndrome.
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Proteus syndrome (PS) is a complex disorder
that consists of asymmetric and mosaic over-
growth that can include connective tissue, the
skeleton, blood vessels, central nervous system
and many other tissues. It was originally named
by Wiedemann in 1983 after the Greek sea god
Proteus, who possessed the ability to transform
himself into any shape. Proteus thus refers to
polymorphism.1 While children with the disorder
have a normal appearance at birth, features of PS
appear during the first year of life and progress
subsequently. As a result of the great variability
in presentation and rarity of this syndrome, it 
remains rather difficult to diagnose. However,
clearer guidelines have recently been proposed.2
Pulmonary bullous changes are a specific criterion
for diagnosis. Only a few studies have mentioned
surgical intervention for pulmonary dysmorphol-
ogy.3,4 We describe a case with emphysematous
bullae who underwent left pneumonectomy.
Case Report
A 25-year-old man had an underlying history of
asymmetric, bilateral overgrowth of the fingers
since the age of 5 months, along with varicose
veins of the left leg since he was 8-years-old. He
underwent amputation for the deformed digits
several times (Figure 1). He suffered from dyspnea
at 19 years of age, and emphysematous changes in
the left lung were noted by radiography. Exertional
dyspnea progressed gradually; he experienced
dyspnea after climbing more than two flights of
stairs.
On admission, lung perfusion revealed an al-
most total absence of perfusion radioactivity in
the left lung. Chest radiography and computed
tomography demonstrated diffuse bullous lesions
in the left lung, with severe deviation of the me-
diastinum to the right side, and compression of
the right lung (Figures 2 and 3). Laboratory data
were within the normal range, except for elevated
C-reactive protein levels (5.04 mmol/L). Spirom-
etry revealed severe restrictive ventilatory defects,
as demonstrated by forced vital capacity (FVC)
of 1.62 L (37.6% of predicted FVC) and a forced
expiratory volume at 1 second (FEV1.0) of 1.24 L
(32.4% of predicted FEV1.0). He underwent left
pneumonectomy. Multiple lobulated bullae in the
left lower lobe, with full occupation of the left
thoracic cavity, were noted. The upper-left lobe
was compressed, with atelectatic changes.
Microscopically, the lung parenchyma showed
diffuse emphysematous changes with multiple
bulla formation (Figure 4A). Scattered foamy cell
aggregates (Figure 4B), calcification and ossifica-
tion were seen sporadically. After surgery, a ge-
neticist was consulted for specific manifestations,
and he was diagnosed with PS. During a 6-month
follow-up, the patient lived an active life and was
fully-functional, with an FVC of 2.53 L (58% of
predicted FVC) and FEV1.0 of 2.29 L (59.1% of
predicted FEV1.0).
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Figure 1. Bilateral palm and finger overgrowth (cerebriform
connective tissue nevus) after several rounds of surgical 
resection.
Figure 3. Computed tomography revealed diffuse emphy-
sematous bullae in the left lung with mediastinal shift.
Figure 2. Large pneumothorax and left lung collapse with
mediastinal shift to the right side.
Pulmonary manifestations of Proteus syndrome
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Discussion
Patients with PS can present with disproportionate
and asymmetric overgrowth of tissues. Although
limb overgrowth is the most common anomaly,
many tissues can be involved.3 According to the
diagnostic criteria, findings of mosaic somatic over-
growth, sporadic occurrence, progressive course,
cerebriform connective nevus over the bilateral
palms, venous malformation, and pulmonary em-
physematous changes lead to the diagnosis.2,3,5
Happle has hypothesized that PS results from
a postzygotic mutation that leads to mosaic effects
that are lethal if the mutation is carried in a non-
mosaic fashion.3,5 There are no documented cases
involving affected offspring. Thus a negative family
history can be meaningful for differential diag-
nosis.5 Although it has been claimed that several
cases have involved phosphatase and tensin ho-
molog gene mutations, patients usually have a
normal chromosome complement.2,4 In our case,
no obvious family history was noted and phos-
phatase and tensin homolog gene testing was
negative.
Pulmonary emphysematous bullous changes
have been noted in 9–13% of cases, but it could
be higher because the pulmonary manifestations
might not be obvious when other features of PS
become prominent.4,5 The distribution of these
bullae could be unilateral or bilateral. There is no
preference for any particular lobe. The cause of
this is unknown and could be related to deficien-
cies or abnormalities of muscular, elastic or fibrous
connective tissue. These patients might develop
symptoms of pulmonary insufficiency, persistent
atelectasis or pneumonia. Such changes can be
relentless and lead to death. Computed tomog-
raphy can be useful for accurate diagnosis.4,5
In young adults, this disease presents similar
symptoms to conditions such as bronchopul-
monary dysplasia, cystic adenomatoid malfor-
mation, intrapulmonary bronchogenic cysts,
postinfectious pneumocele, cystic bronchiectasis,
cystic fibrosis, hydatid disease, histiocytosis X,
Marfan’s syndrome, neurofibromatosis pneumo-
coniosis, α1-antitrypsin deficiency, sarcoidosis
and tuberous sclerosis. However, most of these
diseases involve just a few focal bullous changes
and do not progress over time.4,6
PS treatment focuses on minimizing further
lung damage and avoiding infection. If the distri-
bution is localized, resection of the lesion site
might be an option. If the lesion is too extensive,
lung transplantation might be needed.4
Other thoracic findings include rib overgrowth,
bronchial hamartoma, chest wall masses (lym-
phangioma, hemangioma, or lipoma) and spinal
abnormalities, which can cause respiratory dis-
tress.4 In this situation, surgical intervention
should be considered.3
In conclusion, patients with PS have highly vari-
able symptoms that make diagnosis and treatment
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Figure 4. (A) Left lung showing multiple bullae with scattered calcification on the thick fibrotic walls. (B) Expanded 
emphysematous airspaces often contained foamy histiocytes in the thickened alveolar septum (hematoxylin and eosin).
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complicated. When pulmonary bullous changes
occur, surgical resection should be considered for
the prevention of further pulmonary insufficiency
or infection.
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